Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,215 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical efficacy, tolerability, and safety of SAM486A, a novel polyamine biosynthesis inhibitor, in patients with relapsed or refractory non-Hodgkin's lymphoma: results from a phase II multicenter study.
Pless M, Belhadj K, Menssen HD, Kern W, Coiffier B, Wolf J, Herrmann R, Thiel E, Bootle D, Sklenar I, Müller C, Choi L, Porter C, Capdeville R. Pless M, et al. Among authors: kern w. Clin Cancer Res. 2004 Feb 15;10(4):1299-305. doi: 10.1158/1078-0432.ccr-0977-03. Clin Cancer Res. 2004. PMID: 14977828 Clinical Trial.
Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control study.
Peter RS, Nieters A, Göpel S, Merle U, Steinacker JM, Deibert P, Friedmann-Bette B, Nieß A, Müller B, Schilling C, Erz G, Giesen R, Götz V, Keller K, Maier P, Matits L, Parthé S, Rehm M, Schellenberg J, Schempf U, Zhu M, Kräusslich HG, Rothenbacher D, Kern WV; EPILOC Phase 2 Study Group. Peter RS, et al. Among authors: kern wv. PLoS Med. 2025 Jan 23;22(1):e1004511. doi: 10.1371/journal.pmed.1004511. eCollection 2025 Jan. PLoS Med. 2025. PMID: 39847575 Free article.
Genetic analysis of myeloid neoplasms with der(1;7)(q10;p10).
Okuda R, Ochi Y, Saiki R, Yamanaka T, Terao C, Yoshizato T, Nakagawa MM, Zhao L, Ohyashiki K, Hiramoto N, Sanada M, Handa H, Kasahara S, Miyazaki Y, Sezaki N, Shih LY, Kern W, Kanemura N, Kitano T, Imashuku S, Watanabe M, Creignou M, Chonabayashi K, Usuki K, Ishikawa T, Gotoh A, Atsuta Y, Shiraishi Y, Mitani K, Chiba S, Takaori-Kondo A, Miyano S, Kamatani Y, Haferlach T, Hellström-Lindberg E, Matsuda K, Yoshida Y, Makishima H, Nannya Y, Ogawa S. Okuda R, et al. Among authors: kern w. Leukemia. 2024 Dec 23. doi: 10.1038/s41375-024-02494-2. Online ahead of print. Leukemia. 2024. PMID: 39715854 No abstract available.
Relevance of blast counts for genetic subclassification in MDS.
Huber S, Haferlach T, Hutter S, Hoermann G, Kern W, Haferlach C. Huber S, et al. Among authors: kern w. Leukemia. 2025 Jan;39(1):271-273. doi: 10.1038/s41375-024-02484-4. Epub 2024 Nov 27. Leukemia. 2025. PMID: 39604619 Free PMC article. No abstract available.
Gram-negative bloodstream infections in six German university hospitals, 2016-2020: clinical and microbiological features.
Mischnik A, Baltus H, Walker SV, Behnke M, Gladstone BP, Chakraborty T, Falgenhauer L, Gastmeier P, Gölz H, Göpel S, Häcker GA, Higgins PG, Imirzalioglu C, Käding N, Kramme E, Peter S, Rieg S, Rohde AM, Seifert H, Tacconelli E, Tobys D, Trauth J, Vehreschild MJGT, Xanthopoulou K, Rupp J, Kern WV; DZIF R-NET Study Group. Mischnik A, et al. Among authors: kern wv. Infection. 2024 Nov 25. doi: 10.1007/s15010-024-02430-7. Online ahead of print. Infection. 2024. PMID: 39586959
1,215 results